| Description | Moxifloxacin (Avelox) is a fourth-generation fluoroquinolone that has been shown to be effective against Gram-positive, Gram-negative, and atypical strains, as well as multi-drug resistant Streptococcus pneumoniae. |
| Synonyms | Avelox, Moxeza, 莫西沙星 |
| molecular weight | 401.43 |
| Molecular formula | C21H24FN3O4 |
| CAS | 151096-09-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 95 mg/mL (236.65 mM) |
| References | 1. Miravitlles M , Anzueto A . Moxifloxacin: a respiratory fluoroquinolone[J]. Expert Opinion on Pharmacotherapy, 2015, 9(10):1755-72. |
| Citations | 1. Chen J, Huang J, Shi J, et al. Nestin+ Peyer's patch resident MSCs enhance healing of inflammatory bowel disease through IL‐22‐mediated intestinal epithelial repair. Cell Proliferation. 2022: e13363. 2. Kong Y, Geng Z, Jiang G, et al.Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.Heliyon.2023 |